Vaishali Pharma Limited (VAISHALI) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.22x

Vaishali Pharma Limited (VAISHALI) has a Cash Flow Reinvestment Rate of 0.22x as of September 2025, reinvesting Rs4.60 Million (capex Rs4.60 Million ) from operating cash flow of Rs20.46 Million. See Vaishali Pharma Limited (VAISHALI) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.22x
(Capex + Investments) / Operating CF

Total Reinvested

Rs4.60 Million
Capex + Investments

Operating Cash Flow

Rs20.46 Million
INR

Capital Expenditures

Rs4.60 Million
INR

Vaishali Pharma Limited Cash Flow Reinvestment Rate (2013–2026)

Historical reinvestment intensity for Vaishali Pharma Limited across 10 annual periods. For the full cash flow conversion analysis, see VAISHALI cash generation efficiency.

Annual Cash Flow Reinvestment Rate for Vaishali Pharma Limited (2013–2026)

Year-by-year capital reinvestment analysis for Vaishali Pharma Limited. See VAISHALI FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (INR) Operating CF Capex YoY Change
2026 1.05x Rs4.59 Million Rs4.36 Million Rs4.59 Million ▼ -35.3%
2024 1.63x Rs13.14 Million Rs8.07 Million Rs1.11 Million ▲ +203.5%
2023 0.54x Rs5.79 Million Rs10.80 Million Rs2.97 Million ▼ -58.7%
2022 1.30x Rs17.12 Million Rs13.19 Million Rs8.65 Million ▲ +1004.7%
2021 0.12x Rs2.36 Million Rs20.11 Million Rs1.26 Million ▲ +425.8%
2020 0.02x Rs719.25K Rs32.19 Million Rs526.04K ▼ -94.4%
2019 0.40x Rs11.39 Million Rs28.48 Million Rs2.96 Million ▲ +469.7%
2017 0.07x Rs598.00K Rs8.52 Million Rs35.00K ▲ +280.3%
2016 0.02x Rs847.00K Rs45.88 Million Rs847.00K ▲ +469.9%
2013 0.00x Rs123.00K Rs37.97 Million Rs123.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow